Filing Details

Accession Number:
0001209191-11-009468
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-02-14 19:18:49
Reporting Period:
2011-02-11
Filing Date:
2011-02-14
Accepted Time:
2011-02-14 19:18:49
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1316175 Anthera Pharmaceuticals Inc ANTH Pharmaceutical Preparations (2834) 201852016
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1376260 P. Christopher Lowe C/O Anthera Pharmaceuticals, Inc.
25801 Industrial Boulevard, Suite B
Hayward CA 94545
Vp Of Administration And Cbo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2011-02-11 80,997 $0.00 0 No 4 S Indirect By BioVest III
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect By BioVest III
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 67,645 Direct
Common Stock 9,637 Indirect By spouse
Footnotes
  1. All shares of Common Stock of the Issuer held by Biovest were acquired upon conversion of Series A-1 Preferred Stock of the Issuer.
  2. Mr. Lowe was a principal of BioVest III, which directly held the reported securities. On February 11, 2011, Mr. Lowe transferred his position as manager of the BioVest III for no consideration. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.